SummaryThe purpose of this study was to investigate whether young insulin-dependent diabetic patients still develop peripheral nerve dysfunction when using modern multiple insulin injection therapy and to elucidate if this correlated with various disease parameters. Seventy-five patients, 7 to 20 years old with a duration of diabetes of more than 3 years, and 128 age-matched healthy control subjects underwent bilateral studies of median, peroheal, and sural nerves. Presence of diabetes lowered motor conduction velocity (p < 0.0001), sensory conduction velocity (p < 0.0001) and sensory nerve action potential (p < 0.05) in all examined nerves. The mean change in conduction velocity induced by diabetes was -4.8 m/s in the peroneal nerve, -3.3 m/s in the median motor nerve, -2.6 m/s in the sural nerve and -2.4 m/s in the median sensory nerve. Fifty-seven percent of the patients had abnormal conduction (values outside 95 % predictive interval) which was seen most often in the motor nerves, especially in the peroneal nerve (41%) followed by the median nerve (24 %). In multiple regression analysis, longterm poor metabolic control and increased body length correlated with nerve dysfunction identified in most examined parameters. Three patients had signs or symptoms suggestive of neuropathy. It is concluded that despite modern multiple insulin injection therapy, with reasonably good metabolic control, nerve dysfunction is still common in children and adolescents with insulin-dependent diabetes mellitus. Risk factors are increased height and long-term poor metabolic control. [Diabetologia (1995) 38: 685-692] Key words Insulin-dependent diabetes mellitus, children, neuropathy, nerve conduction velocity, glycaemic control, height.Peripheral neuropathy is a common complication of insulin-dependent diabetes mellitus (IDDM) [1], which increases in frequency with the duration of disease [2][3][4] and is uncommon in children [5]. Although Received: 3 October 1994 and in revised form: 2 December 1994Corresponding author: Dr. L. Hyllienmark, Department of Clinical Neurophysiology, University Hospital, S-58185 Link6ping, Sweden Abbreviations: IDDM, Insulin-dependent diabetes mellitus; MIT, multiple insulin injection therapy; MCV, motor nerve conduction velocity; CMAR compound muscle action potential; DML, distal motor latency; SCV, sensory nerve conduction velocity; SNAP, sensory nerve action potential. unproven, we assume that overt neuropathy with symptoms is preceded by a subclinical form which is important to detect and describe. Electrophysiological studies of nerve conduction velocity are probably our most sensitive tools to quantify early abnormalities [6][7][8]. Such studies exist in paediatric patients on conventional treatment [9-22] but not in patients on modern multiple insulin injection therapy (MIT). The benefits of using MITwith tight metabolic control on diabetic late complications have been clearly shown [23][24][25][26]. The aim of the present study was to ascertain whether young IDDM patients using MIT still d...